Kathryn W Underwood

Title: Kathryn W Underwood: Innovator in Drug Design

Introduction

Kathryn W Underwood is a prominent inventor based in Quincy, MA (US). She has made significant contributions to the field of drug design, holding two patents that showcase her innovative approach to identifying therapeutic agents.

Latest Patents

Her latest patents include "Methods for identifying agents that interact with MAP kinase activated protein kinase 2." This invention focuses on the crystal structures of MK2 and their application in rational drug design methods to identify agents that may interact with the active sites of MK2 proteins. Such agents have the potential to serve as therapeutic agents. Another notable patent is "Crystal structure of yqeJ and uses thereof," which is directed towards the crystal structure of yqeJ and its use in rational drug design methods to identify agents that may interact with the active sites of yqeJ. These agents may prove useful as antibacterial agents.

Career Highlights

Throughout her career, Kathryn has worked with notable companies such as Wyeth and Millennium Pharmaceuticals Limited. Her experience in these organizations has contributed to her expertise in the pharmaceutical industry and drug development.

Collaborations

Some of her coworkers include Mark L Stahl and Kevin Delos Parris, who have collaborated with her on various projects, enhancing the scope of her research and innovations.

Conclusion

Kathryn W Underwood is a distinguished inventor whose work in drug design has the potential to impact therapeutic and antibacterial treatments significantly. Her innovative patents reflect her dedication to advancing the field of pharmaceutical science.